Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-cell Vaccine

Wee EG-T., Kempster S., Ferguson D., Hall J., Ham C., Morris S., Crook A., Gilbert SC., Korber B., Almond N., Hanke T.

DOI

10.20944/preprints202408.0038.v1

Type

Preprint

Publication Date

02/08/2024

Permalink Original publication